FGFR1 and bladder transitional cell carcinoma: Although this study did not directly conduct PDT experiments, the screening of FGFR1 derived from the PDT-related gene network, and the discovery of the cGMP-PKG pathway, provides a new perspective regarding the molecular mechanism of PDT in treating BLCA.